SEARCH

SEARCH BY CITATION

References

  • Akesson, P., Sjöholm, A.G., and Björck, L. (1996) Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J Biol Chem 271: 10811088.
  • Bestebroer, J., Aerts, P.C., Rooijakkers, S.H.M., Pandey, M.K., Köhl, J., Van Strijp, J.A.G., and De Haas, C.J.C. (2010) Functional basis for complement evasion by staphylococcal superantigen-like 7. Cell Microbiol 12: 15061516.
  • Bhakdi, S., and Tranum-Jensen, J. (1983) Molecular composition of the terminal membrane and fluid-phase C5b-9 complexes of rabbit complement. Absence of disulphide-bonded C9 dimers in the membrane complex. Biochem J 209: 753761.
  • Bhakdi, S., Käflein, R., Halstensen, T.S., Hugo, F., Preissner, K.T., and Mollnes, T.E. (1988) Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes. Clin Exp Immunol 74: 459464.
  • Dobrina, A., Pausa, M., Fischetti, F., Bulla, R., Vecile, E., Ferrero, E., et al. (2002) Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo. Blood 99: 185192.
  • Esser, A.F., and Sodetz, J.M. (1988) Membrane attack complex proteins C5b-6, C7, C8 and C9 of human complement. Methods Enzymol 162: 551578.
  • Fernie-king, B.A., Seilly, D.J., Davies, A., and Lachmann, P.J. (2002) Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme. Infect Immun 70: 49084916.
  • Fernie-king, B.A., Seilly, D.J., and Lachmann, P.J. (2004) The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins. Immunology 111: 444452.
  • Frank, M.M., Joiner, K., and Hammer, C. (1987) The function of antibody and complement in the lysis of bacteria. Rev Infect Dis 9 (Suppl. 5): S537S545.
  • Fredslund, F., Laursen, N.S., Roversi, P., Jenner, L., Oliveira, C.L.P., Pedersen, J.S., et al. (2008) Structure of and influence of a tick complement inhibitor on human complement component 5. Nat Immunol 9: 753760.
  • Frick, I.-M., Akesson, P., Rasmussen, M., Schmidtchen, A., and Björck, L. (2003) SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem 278: 1656116566.
  • Haas, P.-J., and Strijp, J.A. (2007) Anaphylatoxins their role in bacterial infection and inflammation. Immunol Res 37: 161175.
  • Hadders, M.A., Bubeck, D., Roversi, P., Hakobyan, S., Forneris, F., Morgan, B.P., et al. (2012) Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. Cell Rep 1: 200207.
  • Janssen, B.J.C., and Gros, P. (2007) Structural insights into the central complement component C3. Mol Immunol 44: 310.
  • Joiner, K., Brown, E., Hammer, C., Warren, K., and Frank, M. (1983) Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing. J Immunol 130: 845849.
  • Joiner, K.A., Brown, E.J., and Frank, M.M. (1984) Complement and bacteria: chemistry and biology in host defense. Annu Rev Immunol 2: 461491.
  • Joisel, F., Leroux-Nicollet, I., Lebreton, J.P., and Fontaine, M. (1983) A hemolytic assay for clinical investigation of human C2. J Immunol Methods 59: 229235.
  • Kashyap, D.R., Wang, M., Liu, L.-H., Boons, G.-J., Gupta, D., and Dziarski, R. (2011) Peptidoglycan recognition proteins kill bacteria by activating protein-sensing two-component systems. Nat Med 17: 676683.
  • Laarman, A.J., Bardoel, B.W., Ruyken, M., Fernie, J., Milder, F.J., Van Strijp, J.A.G., and Rooijakkers, S.H.M. (2012) Pseudomonas aeruginosa alkaline protease blocks complement activation via the classical and lectin pathways. J Immunol 188: 386393.
  • Lachmann, P.J., and Thompson, R.A. (1970) Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor C56 and the participation of C8 and C9. J Exp Med 131: 643657.
  • Langley, R., Wines, B., Willoughby, N., Proft, T., Fraser, J.D., and Basu, I. (2005) The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-FcaRI binding and serum killing of bacteria. J Immunol 174: 29262933.
  • Laursen, N.S., Gordon, N., Hermans, S., Lorenz, N., Jackson, N., Wines, B., et al. (2010) Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus. Proc Natl Acad Sci USA 107: 36813686.
  • Law, S.K.A., and Dodds, A.W. (1997) The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Sci 6: 263274.
  • Leenhouts, C.J., Ramasamy, R., Steen, A., Kok, J., Buist, G., and Kuipers, O.P. (2006) Method to provide bacterial ghosts provided with antigens. US7067639 B2.
  • Martinez, R.J., and Carroll, S.F. (1980) Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme. Infect Immun 28: 735745.
  • Meri, S., Morgan, B.P., Davies, A., Daniels, R.H., Olavesen, M.G., and Waldmann, H. (1990) Human protectin (CD59), an 18 000–20 000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71: 19.
  • Milis, L., Morris, C.A., Sheehan, M.C., Charlesworth, J.A., and Pussell, B.A. (1993) Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9. Clin Exp Immunol 92: 114119.
  • Mollnes, T.E., Lea, T., Harboe, M., and Tschopp, J. (1985) Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma. Scand J Immunol 22: 183195.
  • Müller-Eberhard, H.J. (1985) The killer molecule of complement. J Invest Dermatol 85: 4752.
  • Müller-Eberhard, H.J. (1988) Molecular organization and function of the complement system. Annu Rev Biochem 57: 321347.
  • Nordenfelt, P., Waldemarson, S., Linder, A., Mörgelin, M., Karlsson, C., Malmström, J., and Björck, L. (2012) Antibody orientation at bacterial surfaces is related to invasive infection. J Exp Med 209: 23672381.
  • Nunn, M.A., Sharma, A., Paesen, G.C., Adamson, S., Lissina, O., Willis, A.C., and Nuttall, P.A. (2005) Complement inhibitor of C5 activation from the soft tick Ornithodoros moubata. J Immunol 174: 20842091.
  • Pence, M.A., Rooijakkers, S.H.M., Cogen, A.L., Cole, J.N., Hollands, A., Gallo, R.L., and Nizet, V. (2010) Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. J Innate Immun 2: 587595.
  • Pinkney, M., Beachey, E., and Kehoe, M. (1989) The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity. Infect Immun 57: 25532558.
  • Podack, E.R., and Tschopp, J. (1982a) Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement. Proc Natl Acad Sci USA 79: 574578.
  • Podack, E.R., and Tschopp, J. (1982b) Circular polymerization of the ninth component of complement. Ring closure of the tubular complex confers resistance to detergent dissociation and to proteolytic degradation. J Biol Chem 257: 1520415212.
  • Podack, E.R., Kolb, W.P., and Müller-Eberhard, H.J. (1977) The SC5b-7 complex: formation, isolation, properties, and subunit composition. J Immunol 119: 39.
  • Reynolds, B.L., and Rowley, D. (1969) Sensitization of complement resistant bacterial strains. Nature 221: 12591261.
  • Ricklin, D., Hajishengallis, G., Yang, K., and Lambris, J.D. (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11: 785797.
  • Rooijakkers, S.H.M., Ruyken, M., Roos, A., Daha, M.R., Presanis, J.S., Sim, R.B., et al. (2005) Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 6: 920927.
  • Rooijakkers, S.H.M., Rasmussen, S.L., McGillivray, S.M., Bartnikas, T.B., Mason, A.B., Friedlander, A.M., and Nizet, V. (2010) Human transferrin confers serum resistance against Bacillus anthracis. J Biol Chem 285: 2760927613.
  • Rosado, C.J., Kondos, S., Bull, T.E., Kuiper, M.J., Law, R.H.P., Buckle, A.M., et al. (2008) The MACPF/CDC family of pore-forming toxins. Cell Microbiol 10: 17651774.
  • Shepard, L.A., Heuck, A.P., Hamman, B.D., Rossjohn, J., Parker, M.W., Ryan, K.R., et al. (1998) Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an alpha-helical to beta-sheet transition identified by fluorescence spectroscopy. Biochemistry 37: 1456314574.
  • Silhavy, T.J., Kahne, D., and Walker, S. (2010) The bacterial cell envelope. Cold Spring Harb Perspect Biol 2: a000414. doi:10.1101/cshperspect.a000414.
  • Skattum, L., Van Deuren, M., Van der Poll, T., and Truedsson, L. (2011) Complement deficiency states and associated infections. Mol Immunol 48: 16431655.
  • Steckel, E.W., Welbaum, B.E., and Sodetzs, J.M. (1983) Evidence of direct insertion of terminal complement proteins into cell membrane bilayers during cytolysis. J Biol Chem 258: 43184324.
  • Tedesco, B.F., Pausa, M., Nardon, E., Introna, M., Mantovani, A., and Dobrina, A. (1997) The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med 185: 16191627.
  • Tedesco, F., Rottini, G., and Patriarca, P. (1981) Modulating effect of the late-acting components of the complement system on the bactericidal activity of human polymorphonuclear leukocytes on E. coli 0111:B4. J Immunol 127: 19101915.
  • Tschopp, J., Engel, A., and Podack, E.R. (1984) Molecular weight of poly (C9). J Biol Chem 259: 19221928.
  • Tschopp, J., Podack, E.R., and Müller-Eberhard, H.J. (1985) The membrane attack complex of complement C5b-8 complex as accelerator of C9 polymerization. J Immunol 134: 495499.
  • Tschopp, J., Chonn, A., Hertig, S., and Frencht, L.E. (1993) Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8b, and the b domain of C9. J Immunol 151: 21592165.
  • Walker, B., and Bayley, H. (1995) Key residues for membrane binding, oligomerization, and pore forming activity of staphylococcal alpha-hemolysin identified by cysteine scanning mutagenesis and targeted chemical modification. J Biol Chem 270: 2306523071.
  • Walport, M.J. (2001) Complement first of two parts. N Engl J Med 344: 10581066.
  • Yamamoto, K.-I., and Migata, S. (1983) Mechanisms for the spontaneous formation of covalently linked polymers of the terminal membranolytic complement protein (C9). J Biol Chem 258: 78877889.